Clinical trials: Hepatitis B Vaccination

Vaccination Adverse Event, Immunogenicity, Vaccine

Study Interchangeability Hep-B Vaccine Administered at Birth Dose

• Not yet recruiting
• Age: 0 to 3 days
• Phase 3
• Vaccines
• Injection or infusion

This trial is a randomized, double-blind, two arms parallel groups, prospective intervention study.

Trial name

NCT07854847

Testing

In-house Hepatitis B Vaccine, Registered Hepatitis B Vaccine

Volunteers

270 people, healthy volunteers welcome

Sponsor

PT Bio Farma